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Guideline
European Stroke Organisation
expedited recommendation for the
use of short-term dual antiplatelet
therapy early after minor stroke
and high-risk TIA
Jesse Dawson1 , Aine Merwick2 , Alastair Webb3 ,
Martin Dennis4, Julia Ferrari5 and Ana Catarina Fonseca6 ;
for the European Stroke Organisation
Abstract
Prevention of early recurrent ischaemic stroke remains a priority in people with TIA or ischaemic stroke. A number of
trials have recently been completed assessing the efficacy of short-term dual antiplatelet therapy (DAPT) versus single
antiplatelet therapy early after minor or moderate stroke or high-risk TIA. We present an Expedited Recommendation
for use of dual antiplatelet therapy early after ischaemic stroke and TIA on behalf of the ESO Guideline Board. We make
a strong recommendation based on high quality of evidence for use of 21-days of dual antiplatelet therapy with aspirin
and clopidogrel in people with a non-cardioembolic minor ischaemic stroke or high-risk TIA in the past 24 hours. We
make a weak recommendation based on moderate quality evidence for 30-days of dual antiplatelet therapy with aspirin
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